Ethyl orthoformate → Ro 14-7437

HRID 67318

반응식

HRID 67318 반응식
[NH2:1][C:2](=[C:8]1[CH2:14][N:13]([CH3:15])[C:12](=[O:16])[C:11]2[CH:17]=[CH:18][CH:19]=[CH:20][C:10]=2[NH:9]1)[C:3]([O:5][CH2:6][CH3:7])=[O:4].[CH:21](OCC)(OCC)OCC>C1(C)C=CC=CC=1>[CH3:15][N:13]1[C:12](=[O:16])[C:11]2[CH:17]=[CH:18][CH:19]=[CH:20][C:10]=2[N:9]2[CH:21]=[N:1][C:2]([C:3]([O:5][CH2:6][CH3:7])=[O:4])=[C:8]2[CH2:14]1

참가 물질

4

반응물 2

HCID 31214Ethyl orthoformateHCID 70541641ethyl alpha-amino-1,3,4,5-tetrahydro-4-methyl-5-oxo-2H-1,4-benzodiazepin-2-ylidene-acetate

생성물 1

HCID 127597Ro 14-7437

시약·촉매·용매 1

HCID 1140Toluene용매

실험 절차

1.10 g of ethyl α-amino-1,3,4,5-tetrahydro-4-methyl-5-oxo-2H-1,4-benzodiazepin-2-ylidene-acetate are dissolved in 15 ml of toluene and treated with 1.0 ml of triethyl orthoformate. The mixture is heated to reflux for 50 minutes, subsequently cooled and evaporated in vacuo. The crystalline residue is suspended in 25 ml of ethyl acetate, filtered off and dried. There is obtained ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine-3-carboxylate of melting point 165° C.

후처리

  1. temperatureThe mixture is heated
  2. temperatureto reflux for 50 minutes
  3. temperaturesubsequently cooled
  4. customevaporated in vacuo
  5. filtrationfiltered off
  6. customdried

출처 및 근거

ORD 기록
ord-6282bb24c0b34c5584d9bba722813b52
출처 데이터셋
uspto-grants-1982_08
특허 번호
US04346030

연결된 노트

불러오는 중…